Amedisys, Inc. (NASDAQ:AMED) Stake Lowered by Guggenheim Capital LLC

Guggenheim Capital LLC decreased its stake in Amedisys, Inc. (NASDAQ:AMED - Free Report) by 40.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,489 shares of the health services provider's stock after selling 3,080 shares during the period. Guggenheim Capital LLC's holdings in Amedisys were worth $408,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of the stock. Blue Trust Inc. lifted its stake in shares of Amedisys by 55.1% in the fourth quarter. Blue Trust Inc. now owns 349 shares of the health services provider's stock worth $34,000 after acquiring an additional 124 shares in the last quarter. Xponance Inc. raised its position in shares of Amedisys by 3.5% during the 4th quarter. Xponance Inc. now owns 4,349 shares of the health services provider's stock worth $395,000 after purchasing an additional 148 shares during the period. Inspire Investing LLC lifted its stake in Amedisys by 3.6% in the fourth quarter. Inspire Investing LLC now owns 4,405 shares of the health services provider's stock valued at $400,000 after buying an additional 155 shares during the last quarter. Nisa Investment Advisors LLC boosted its stake in Amedisys by 1.2% during the 4th quarter. Nisa Investment Advisors LLC now owns 15,150 shares of the health services provider's stock valued at $1,375,000 after purchasing an additional 180 shares during the period. Finally, Retirement Systems of Alabama grew its holdings in Amedisys by 0.5% in the 4th quarter. Retirement Systems of Alabama now owns 39,822 shares of the health services provider's stock worth $3,615,000 after buying an additional 181 shares in the last quarter. 94.36% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

AMED has been the topic of a number of research analyst reports. Royal Bank of Canada reissued an "outperform" rating and set a $100.00 price target on shares of Amedisys in a report on Wednesday, April 16th. Stephens reissued an "equal weight" rating and set a $101.00 target price on shares of Amedisys in a research note on Tuesday, March 4th. Four analysts have rated the stock with a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average price target of $100.75.

Amedisys Price Performance

Amedisys stock traded up $0.47 during midday trading on Friday, hitting $95.67. The company's stock had a trading volume of 605,848 shares, compared to its average volume of 409,924. Amedisys, Inc. has a 12 month low of $82.15 and a 12 month high of $98.95. The stock's 50-day moving average price is $92.49 and its 200-day moving average price is $91.77. The company has a market capitalization of $3.14 billion, a PE ratio of 37.96, a price-to-earnings-growth ratio of 1.78 and a beta of 0.96. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.05.

Amedisys (NASDAQ:AMED - Get Free Report) last issued its quarterly earnings results on Wednesday, April 23rd. The health services provider reported $1.25 earnings per share for the quarter, topping analysts' consensus estimates of $1.13 by $0.12. Amedisys had a return on equity of 12.20% and a net margin of 3.57%. The firm had revenue of $594.78 million for the quarter, compared to analysts' expectations of $597.43 million. During the same quarter last year, the business posted $1.03 EPS. Amedisys's revenue was up 4.1% on a year-over-year basis. Analysts anticipate that Amedisys, Inc. will post 4.4 earnings per share for the current fiscal year.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.